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Nuclear protein in testis (NUT) midline carcinomas are un-
common, recently described, fatal neoplasm that are character-
ized by rearrangement of the NUT gene on 15q14.1 Since the 
first case of NUT midline carcinoma was reported as an undif-
ferentiated carcinoma with a t(15;19) translocation in 1991,2 
more than 50 cases have been reported.3 Because of the unique 
chromosomal translocation and predilection for occurrence in 
midline structures, they have been termed NUT midline carci-
nomas. However, tumors outside the midline have been report-
ed, including the salivary gland, bladder, and other sites.1,3-5 We 
encountered a case of NUT midline carcinoma confirmed by 
NUT specific immunohistochemistry (IHC) using cytologic 
and histologic specimens. Herein, we present the first case re-
port on immunocytologic features of NUT midline carcinoma 
arising in the parotid gland.
CASE REPORT
A 12-year-old boy without a significant past medical history 
presented with a parotid mass. The neck magnetic resonance 
imaging (MRI) revealed a 2.4-cm-sized mass with irregular 
margins in the deep subcutaneous fat layer of the right cheek 
(Fig. 1). Several other masses with similar characteristic signal 
changes as the right cheek mass were identified in the deep fat 
layer in the right mandibular angle and submandibular area.
A fine needle aspiration was performed on the right cheek 
mass. The aspirated smear had a necrotic background and 
showed both syncytial tissue fragments and scattered single cells 
(Fig. 2). The smear showed tiny necrotic foci. The tumor cells 
were relatively small (nucleus about 9 µm, cytoplasm about 20 
µm in the longest diameter) and had pale cytoplasm and indis-
tinct cell borders. The tumor nuclei were ovoid with small nu-
cleoli and the chromatin was evenly dispersed and hyperchro-
matic. The nuclear membranes had slight irregularity with oc-
casional grooves. Most single cells had naked nuclei and occa-
sional mitotic figures were identified. Squamous or glandular 
differentiation was not evident. A right total parotidectomy 
with neck dissection was performed for tumor removal and 
pathologic confirmation of the tumor subtype.
Microscopically, it revealed numerous tumor islands forming 
sheets or nests within the desmoplastic stroma (Fig. 3). The tu-
mor cells had similar cytologic characteristics to those of the as-
pirated smear (Fig. 3). Metastasis to the cervical lymph nodes as 
well as perineural and lymphatic invasion was found. As the tu-
mor cells did not demonstrate any differentiation, diverse im-
munohistochemical stains including pancytokeratin (Leica Mi-
crosystem, Novocastra, Newcastle upon Tyne, UK), vimentin 
(Dako, Carpinteria, CA, USA), p63 (Biogenex, San Ramon, CA, 
USA), S-100 (Dako), CD34 (Leica Microsystem), synaptophysin 
(Leica Microsystem), chromogranin A (Leica Microsystem), 
CD56 (Leica Microsystem), smooth muscle actin (Dako), des-
min (Dako), Wilms tumor-1 (Leica Microsystem), and CD99 
(Dako) were performed. The tumor cells expressed only pancy-
tokeratin and p63 (Fig. 3).
At first glance, the most possible diagnosis of this case was 
poorly differentiated squamous cell carcinoma based on the im-
munohistochemical staining results. However, we hesitated to 
report squamous cell carcinoma owing to the patient’s young 
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age, and lack of smoking history or squamous differentiation on 
light microscopic examination. Finally, we performed the NUT 
(1:100, C52B1, Cell Signaling Technology, Danvers, MA, 
USA) immunostain using tissue section as well as cell block 
section from the aspirate. The tumor nuclei showed diffuse 
strong immunoreactivity to NUT and we were able to diagnose 
NUT midline carcinoma (Figs. 2, 3). 
Despite intensive postoperative chemo-radiation therapy, two 
recurrent events occurred within 1 year after the initial opera-
tion. The patient experienced disease progression and expired 2 
years after the first presentation.
DISCUSSION
NUT midline carcinoma is a rare and aggressive subset of 
squamous cell carcinoma, genetically defined by chromosomal 
translocation involving the NUT gene.1 In about two thirds of 
NUT midline carcinomas, NUT is fused to BRD4 [t(15;19)] 
and in the  remainder of cases, it is either fused to BRD3 [t(9;15)] 
or to unknown partner (NUT-variant).4 This cancer affects pri-
marily the mediastinum, head and neck, but it arises in many 
other organs, such as the urinary bladder, iliac bone, pancreas, 
parotid gland, and lung.3-5 It occurs in people of any ages (range, 
0 to 78 years) or gender. NUT midline carcinoma is refractory to 
Fig. 1. Radiologic findings. Neck magnetic resonance imaging re-
veals an infiltrative mass (arrow) with strong gadolinium enhance-
ment, located in the deep fat layer of the right cheek.
Fig. 2. Cytologic findings. (A) The smear shows many cohesive clusters with single scattered cells. (B) Tumor cell necrosis is found. (C) The 
tumor cells are relatively small and uniform with irregular ovoid nuclei, small nucleoli, and occasional mitosis. (D) NUT immunohistochemistry 
(C52) using the aspirated smear slide reveals diffuse nuclear immunoreactivity.
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Fig. 3. Histopathologic findings. (A) The tumor is composed of sheets of poorly differentiated cells with desmoplastic stroma. (B, C) The tumor 
cells have relatively small and irregular ovoid nuclei with small nucleoli. Individual cell necrosis (arrow), frequent mitosis, and tiny necrotic foci 
(arrowhead) are present. Immunohistochemical stains reveal diffuse nuclear immunoreactivity to p63 (D) and the NUT specific antibody (E).
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conventional chemotherapy and radiotherapy. It has a fatal clini-
cal course with median survival of 6.7 months.6 Two therapeutic 
agents targeting the BRD4-NUT oncogene (bromodomain in-
hibitors and histone deacetylase inhibitors) have emerged and are 
in phase I clinical trials.4 Therefore, an early and proper diagnosis 
of NUT midline carcinoma would become essential.
Unfortunately, the histopathology of NUT midline carcino-
mas is not diagnostic. They are composed of sheets or nests of 
undifferentiated tumor cells with varying degrees of squamous 
differentiation.4,7 Large areas of coagulative necrosis and exten-
sive desmoplastic stroma may be present.7 Their morphology 
overlaps with that of many other poorly differentiated malig-
nant neoplasm and NUT midline carcinoma is frequently mis-
diagnosed as squamous cell carcinoma, poorly differentiated 
carcinoma, sinonasal undifferentiated carcinoma, Ewing sarco-
ma, leukemia, thymic carcinoma (if in the thorax), or neuro-
blastoma.7,8 However, there are a few morphologic features 
which could suggest NUT midline carcinoma such as relatively 
monotonous and round tumor cells and foci of abrupt squa-
mous differentiation in about 50% of cases.3,4,7
Bellizzi et al.9 and Zhu et al.10 described the cytologic features 
of NUT translocated carcinoma. The cytologic characteristics 
was a highly cellular, predominantly discohesive pattern of rela-
tively small tumor cells with a round nucleus, scant cytoplasm, 
irregular nuclear contours, variably prominent nucleoli, and 
identifiable mitotic figures. Overt keratinization, which may be 
typical in surgical specimens, was not identified, while occasional 
cells with a denser cytoplasm were noted in one case. The origi-
nal cytologic diagnoses were “consistent with sinonasal undiffer-
entiated carcinoma” and “consistent with metastatic carcinoma.” 
Distinction of NUT midline carcinoma from other undifferenti-
ated carcinomas without any ancillary tests is nearly impossible 
in cytology specimens. However, despite the absence of patho-
gnomic cytologic or histologic features, it is critical to know this 
entity and to consider confirmative tests because NUT midline 
carcinoma has a very aggressive clinical course and might be 
managed by other types of chemotherapeutic regimens.
For a confirmative diagnosis of NUT midline carcinoma, 
karyotyping, fluorescence in situ hybridization (FISH), or NUT 
mRNA by reverse transcription polymerase chain reaction can 
be used to detect the NUT gene rearrangement.4 However, 
these tests are not widely available and have not been commer-
cialized. Recently, both monoclonal8 and polyclonal7 NUT spe-
cific antibodies were developed for IHC. Haack et al.8 assessed 
the accuracy of monoclonal NUT (C52) antibody to detect 
NUT rearranged carcinoma confirmed by FISH. They demon-
strated that NUT IHC had a sensitivity of 87% and a specifici-
ty of 100% when diagnosing NUT midline carcinoma among 
nongerm cell tumors. Generally, germ cells in the testis and oo-
cytes are stained with NUT antibody. Germ cell tumors such as 
dysgerminoma, seminoma, and embryonal carcinoma were re-
ported to show focal (<5%), weak nuclear staining with C52, 
presumably due to the normal expression of NUT in tumor 
cells, whereas NUT midline carcinomas showed diffuse 
(>50%), speckled nuclear staining.8 Thus, IHC using the 
NUT specific antibody can be used as an alternative diagnostic 
test if the tumor cells show diffuse immunoreactivity to the 
NUT specific antibody.
Almost all NUT midline carcinomas show immunoreactivity 
to p63,5,7,9 reflecting the squamous nature of this tumor. How-
ever, it is very unique in that it is characterized by a single 
chromosomal translocation like leukemia/lymphoma, in con-
trast to complex karyotypes and aneuploidy in typical squa-
mous cell carcinomas. In addition, none of the smoking-related 
squamous cell carcinoma of the head and neck showed NUT 
immunostaining or gene rearrangement.8 This suggests that 
NUT midline carcinoma might arise through a different patho-
genesis. The NUT oncogene may represent a short-cut to squa-
mous cancer, bypassing multiple processes of environmentally-
acquired mutations and genetic instability in conventional 
squamous cell carcinoma.3,4
In this report, we presented a case of NUT midline carcino-
ma, which developed in the parotid gland of an adolescent boy. 
NUT midline carcinoma is a recently described, uncommon 
disease with a fatal outcome and is underdiagnosed due to non-
specific morphologic features. In cases with poorly differentiat-
ed malignancy of the head and neck, it is important to be aware 
of this entity and to perform NUT immunostaining in a cytol-
ogy specimen for proper diagnosis and patient management.
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